Credit: Optibrium.

Matthew Segall, PhD profile page

CEO

at Optibrium

Matthew Segall is CEO of Optibrium. He has an MSc in computation from the University of Oxford and a PhD in theoretical physics from the University of Cambridge. Since 2001, Matthew has led teams developing predictive models and intuitive decision-support and visualization tools for drug discovery. Matt has published over 40 peer-reviewed papers and book chapters on computational chemistry, cheminformatics and drug discovery. In 2009 he led a management buyout of the StarDrop™ business to found Optibrium, which develops novel technologies and ground-breaking AI software and services, including Cerella™ and Inspyra™, that improve the efficiency and productivity of drug discovery.

Areas of Expertise

Computational chemistry

Chemoinformatics

Drug discovery

Got a Question for Matthew Segall, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Published Content

Total: 1

Glowing stick and ball molecules representing AI-driven generative chemistry.

Article

Generative Chemistry: Navigating Vast Chemical Space in Drug Discovery

This article explores how generative chemistry accelerates drug design, identifies novel compounds and complements traditional computational tools.